- Home
- JBLU vs ATRC Comparison
JBLU vs ATRC Comparison
Compare JBLU & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- ATRC
- Stock Information
- Founded
- JBLU 1998
- ATRC 2000
- Country
- JBLU United States
- ATRC United States
- Employees
- JBLU N/A
- ATRC N/A
- Industry
- JBLU Air Freight/Delivery Services
- ATRC Medical/Dental Instruments
- Sector
- JBLU Consumer Discretionary
- ATRC Health Care
- Exchange
- JBLU Nasdaq
- ATRC Nasdaq
- Market Cap
- JBLU 2.0B
- ATRC 1.7B
- IPO Year
- JBLU N/A
- ATRC 2005
- Fundamental
- Price
- JBLU $4.29
- ATRC $32.32
- Analyst Decision
- JBLU Sell
- ATRC Strong Buy
- Analyst Count
- JBLU 9
- ATRC 9
- Target Price
- JBLU $5.11
- ATRC $52.00
- AVG Volume (30 Days)
- JBLU 26.1M
- ATRC 583.1K
- Earning Date
- JBLU 10-28-2025
- ATRC 10-29-2025
- Dividend Yield
- JBLU N/A
- ATRC N/A
- EPS Growth
- JBLU N/A
- ATRC N/A
- EPS
- JBLU N/A
- ATRC N/A
- Revenue
- JBLU $9,095,000,000.00
- ATRC $518,304,999.00
- Revenue This Year
- JBLU N/A
- ATRC $16.90
- Revenue Next Year
- JBLU $8.00
- ATRC $12.29
- P/E Ratio
- JBLU N/A
- ATRC N/A
- Revenue Growth
- JBLU N/A
- ATRC 15.80
- 52 Week Low
- JBLU $3.34
- ATRC $28.29
- 52 Week High
- JBLU $8.31
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- JBLU 42.08
- ATRC 31.64
- Support Level
- JBLU $4.01
- ATRC $30.94
- Resistance Level
- JBLU $4.29
- ATRC $37.28
- Average True Range (ATR)
- JBLU 0.20
- ATRC 1.73
- MACD
- JBLU -0.03
- ATRC -0.50
- Stochastic Oscillator
- JBLU 38.75
- ATRC 18.50
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.